Home＞ORGANIZATION

• Astellas Becomes 1st Japan Maker to Join PhRMA Leadership

  February 14.2018

• Private Univ. Group Encourages “Single-Product, Single-Price” Deals in Response to New Distribution GL, Tougher Medical Fee Cut Rules

  February 9.2018
  

• “Unprecedented Reforms to Take Place as a Result of Chuikyo’s Leadership”: JMA Pres. Yokokura

  February 8.2018
  

• Japan Could Miss Out on Wave 1 of Drug Development, Re-Do and Do Right on PMP: PhRMA

  January 30.2018
  

• Japan Pharma Leader Says Pricing Overhaul Would Not Expand Drug Lag

  January 18.2018
  

• Exclude 50 Yen or Lower Price Generics from “Off-Year” Re-Pricing: JGA Chief

  January 15.2018
  

• Pharma Leaders Air Bleak Outlook on New PMP Scheme at New Year’s Reception

  January 10.2018
  

• JPMA to Call for Improvements in PMP-Eligibility Criteria, Company Requirements: Chief

  December 22.2017

• Continued Discussions Needed for PMP-Eligible Products, Company Criteria: FPMAJ/JPMA

  December 22.2017

• PhRMA/EFPIA Rap Japan’s Drug Pricing Reform, Warn of Grave Consequences

  December 21.2017

＜ Prev 1 2 3 4 5 6 7 8 9 10 Next ＞